BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25080326)

  • 1. Equine mesenchymal stromal cells and embryo-derived stem cells are immune privileged in vitro.
    Paterson YZ; Rash N; Garvican ER; Paillot R; Guest DJ
    Stem Cell Res Ther; 2014 Jul; 5(4):90. PubMed ID: 25080326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of human mesenchymal stromal cells with peripheral blood mononuclear cells in a Mitogenic proliferation assay.
    Herzig MC; Christy BA; Montgomery RK; Delavan CP; Jensen KJ; Lovelace SE; Cantu C; Salgado CL; Cap AP; Bynum JA
    J Immunol Methods; 2021 May; 492():113000. PubMed ID: 33609532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
    Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA
    J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment.
    Smith RK; Korda M; Blunn GW; Goodship AE
    Equine Vet J; 2003 Jan; 35(1):99-102. PubMed ID: 12553472
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of genes involved in immune response and in vitro immunosuppressive effect of equine MSCs.
    Remacha AR; Barrachina L; Álvarez-Arguedas S; Ranera B; Romero A; Vázquez FJ; Zaragoza P; Yañez R; Martín-Burriel I; Rodellar C
    Vet Immunol Immunopathol; 2015 Jun; 165(3-4):107-18. PubMed ID: 25977164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to allogeneic equine mesenchymal stromal cells.
    Kamm JL; Riley CB; Parlane NA; Gee EK; McIlwraith CW
    Stem Cell Res Ther; 2021 Nov; 12(1):570. PubMed ID: 34772445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
    Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
    Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term assays for mesenchymal stromal cell immunosuppression of T-lymphocytes.
    Herzig MC; Christy BA; Montgomery RK; Cantu-Garza C; Barrera GD; Lee JH; Mucha N; Talackine JR; Abaasah IA; Bynum JA; Cap AP
    Front Immunol; 2023; 14():1225047. PubMed ID: 37822938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients.
    Cui R; Rekasi H; Hepner-Schefczyk M; Fessmann K; Petri RM; Bruderek K; Brandau S; Jäger M; Flohé SB
    Stem Cell Res Ther; 2016 Jul; 7(1):88. PubMed ID: 27388156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysis and phenotypic modulation of mesenchymal stromal cells upon blood contact triggers anti-inflammatory skewing of the peripheral innate immune repertoire.
    Davies LC; Queckbörner S; Jylhä CE; Andrén AT; Forshell TZP; Blanc KL
    Cytotherapy; 2023 Sep; 25(9):956-966. PubMed ID: 37354149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum IFN-γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients.
    Wang D; Wang S; Huang S; Zhang Z; Yuan X; Feng X; Lu L; Sun L
    Stem Cells Transl Med; 2017 Sep; 6(9):1777-1785. PubMed ID: 28755405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
    Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
    Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes.
    Zanone MM; Favaro E; Miceli I; Grassi G; Camussi E; Caorsi C; Amoroso A; Giovarelli M; Perin PC; Camussi G
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3788-97. PubMed ID: 20466784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equine Fetal, Adult, and Embryonic Stem Cell-Derived Tenocytes Are All Immune Privileged but Exhibit Different Immune Suppressive Properties In Vitro.
    McClellan A; Paterson YZ; Paillot R; Guest DJ
    Stem Cells Dev; 2019 Nov; 28(21):1413-1423. PubMed ID: 31507234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The allogeneic umbilical cord mesenchymal stem cells regulate the function of T helper 17 cells from patients with rheumatoid arthritis in an in vitro co-culture system.
    Wang Q; Li X; Luo J; Zhang L; Ma L; Lv Z; Xue L
    BMC Musculoskelet Disord; 2012 Dec; 13():249. PubMed ID: 23237239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia Pre-Conditioned Embryonic Mesenchymal Stem Cell Secretome Reduces IL-10 Production by Peripheral Blood Mononuclear Cells.
    Lotfinia M; Lak S; Mohammadi Ghahhari N; Johari B; Maghsood F; Parsania S; Sadegh Tabrizi B; Kadivar M
    Iran Biomed J; 2017 Jan; 21(1):24-31. PubMed ID: 27132108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placenta-derived multipotent mesenchymal stromal cells: a promising potential cell-based therapy for canine inflammatory brain disease.
    Amorim RM; Clark KC; Walker NJ; Kumar P; Herout K; Borjesson DL; Wang A
    Stem Cell Res Ther; 2020 Jul; 11(1):304. PubMed ID: 32698861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-derived equine mesenchymal stem cells suppress proliferation of mismatched lymphocytes.
    Ranera B; Antczak D; Miller D; Doroshenkova T; Ryan A; McIlwraith CW; Barry F
    Equine Vet J; 2016 Mar; 48(2):253-60. PubMed ID: 25582202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of platelet lysate on immunoregulatory characteristics of equine mesenchymal stromal cells.
    Moellerberndt J; Niebert S; Fey K; Hagen A; Burk J
    Front Vet Sci; 2024; 11():1385395. PubMed ID: 38725585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.